EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma

Anna Caliò, Stefano Marletta, Lavinia Stefanizzi, Lisa Marcolini, Matteo Rotellini, Gabriella Serio, Elena Bariani, Caterina Vicentini, Serena Pedron, Filippo M Martelli, Pietro Antonini, Matteo Brunelli und 1 weitere

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2024.100561 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Modern Pathology, 2024. Verfasst von Anna Caliò und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pathology, Department of Diagnostic and Public Health, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Peritoneal Neoplasms, Fumarate Hydratase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fumarate hydratase (FH)-deficient renal cell carcinomas are rare neoplasms characterized by wide morphologic heterogeneity and pathogenetic mutations in the FH gene. They often show aggressive behavior with rapid diffusion to distant organs, so novel therapeutic scenarios have been explored, including EGFR inhibitors and PD-L1 expression for targeted immunotherapy. Herein, we investigated a series of 11 primary FH-deficient renal cell carcinomas and 7 distant metastases to evaluate tumor heterogeneity even in metastatic sites and estimate the specific spread rates to various organs. Furthermore, the tumors were tested for immunohistochemical PD-L1 expression and EGFR mutations. Most metastatic cases involved the abdominal lymph nodes (4/7; 57%), followed by the peritoneum (3/7; 42%), the liver (2/7; 29%), and the lungs (1/7; 14%). Six metastatic localizations were histologically documented, revealing a morphologic heterogeneous architecture often differing from that of the corresponding primary renal tumor. Peritoneal involvement morphologically resembled a benign reactive mesothelial process or primary peritoneal mesothelioma, thus advocating to perform an accurate immunohistochemical panel, including PAX8 and FH, to reach a proper diagnosis. A pure low-grade succinate dehydrogenase-looking primary FH-deficient renal cell carcinoma was also recorded. As for therapy, significant PD-L1 labeling was found in 60% of primary renal tumors, whereas none of them carried pathogenetic EGFR mutations. Our data show that FH-deficient renal cell carcinoma may be morphologically heterogeneous in metastases as well, which involve the lymph nodes, the liver, and the peritoneum more frequently than other renal tumors. Due to the high frequency of this latter (42%), pathologists should always be concerned about ruling out mesothelial-derived mimickers, and the occurrence of rarer, primary, low-grade-looking types. Finally, contrary to EGFR mutations, PD-L1 expression could be a possible predictive biomarker for the therapy of these tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellPeritoneal NeoplasmsFumarate HydrataseBiomarkers, TumorHumansFemaleMiddle AgedMaleAgedAdultDiagnosis, DifferentialB7-H1 AntigenMesothelioma, MalignantMutationImmunohistochemistry

Stichwörter der Autor:innen

cancer biomarkersdiagnostic pitfalldifferential diagnosisfumarate hydrataseintratumoral heterogeneityrenal cell carcinoma

Substanzen

Fumarate HydrataseBiomarkers, TumorB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Section of Pathology, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
  • Section of Pathology, Department of Diagnostic and Public Health, University of Verona, Verona, Italy; Division of Pathology, Humanitas Istituto Clinico Catanese, Catania, Italy.
  • Department of Pathology and Laboratory Medicine, Pederzoli Hospital, Peschiera, Verona, Italy.
  • Anatomia Patologica Massa Carrara Azienda Toscana Nord Ovest, Italy.
  • Pathology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Italy.
  • Unit of Anatomic Pathology, Department of Oncology, Bellaria Hospital, Bologna, Italy.

Zitieren

APA

Caliò, A., Marletta, S., Stefanizzi, L., Marcolini, L., Rotellini, M., Serio, G., Bariani, E., Vicentini, C., Pedron, S., Martelli, F. M., Antonini, P., Brunelli, M., & Martignoni, G. (2024). Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100561

Vancouver

Caliò A, Marletta S, Stefanizzi L, Marcolini L, Rotellini M, Serio G, et al. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100561

BibTeX
@article{Cali2024,
  author = {Caliò, Anna and Marletta, Stefano and Stefanizzi, Lavinia and Marcolini, Lisa and Rotellini, Matteo and Serio, Gabriella and Bariani, Elena and Vicentini, Caterina and Pedron, Serena and Martelli, Filippo M and Antonini, Pietro and Brunelli, Matteo and Martignoni, Guido},
  title = {Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2024.100561}
}
Kostenlos starten →